RNF40 | ring finger protein 40, E3 ubiquitin protein ligase | 16p11.2-p11.1 | 0.4 | 0.618 | 0
|
ATXN2L | ataxin 2-like | 16p11 | 0.311 | 0.415 | 0
|
KIAA0556 | KIAA0556 | 16p12.1-p11.2 | 0.302 | 0.474 | 0
|
SETD1A | SET domain containing 1A | 16p11.2 | 0.296 | 0.487 | 0
|
XPO6 | exportin 6 | 16p11.2 | 0.295 | 0.528 | 0
|
ZKSCAN2 | zinc finger with KRAB and SCAN domains 2 | 16p12.1 | 0.293 | 0.426 | 0
|
ZNF646 | zinc finger protein 646 | 16p11.2 | 0.29 | 0.379 | 3.1e-16
|
FBRS | fibrosin | 16p11.2 | 0.284 | 0.392 | 0
|
CD2BP2 | CD2 (cytoplasmic tail) binding protein 2 | 16p11.2 | 0.281 | 0.372 | 1.74e-15
|
EARS2 | glutamyl-tRNA synthetase 2, mitochondrial | 16p12.2 | 0.27 | 0.409 | 0
|
POLR3E | polymerase (RNA) III (DNA directed) polypeptide E (80kD) | 16p12 | 0.269 | 0.459 | 0
|
MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) | 16p11.2 | 0.266 | 0.346 | 2.41e-13
|
CLEC16A | C-type lectin domain family 16, member A | 16p13.13 | 0.266 | 0.433 | 0
|
TAOK2 | TAO kinase 2 | 16p11.2 | 0.265 | 0.369 | 3.52e-15
|
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 16p13.3 | 0.262 | 0.482 | 0
|
COG7 | component of oligomeric golgi complex 7 | 16p12.2 | 0.26 | 0.408 | 0
|
ZNF48 | zinc finger protein 48 | 16p11.2 | 0.258 | 0.354 | 6.3e-14
|
TBC1D10B | TBC1 domain family, member 10B | 16p11.2 | 0.256 | 0.43 | 0
|
SPNS1 | spinster homolog 1 (Drosophila) | 16p11.2 | 0.247 | 0.413 | 0
|
DCTN5 | dynactin 5 (p25) | 16p12.1 | 0.246 | 0.465 | 0
|
NFATC2IP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein | 16p11.2 | 0.246 | 0.298 | 3.87e-10
|
KNOP1 | lysine-rich nucleolar protein 1 | 16p12.3 | 0.243 | 0.421 | 0
|
UBFD1 | ubiquitin family domain containing 1 | 16p12.1 | 0.242 | 0.487 | 0
|
TUFM | Tu translation elongation factor, mitochondrial | 16p11.2 | 0.241 | 0.45 | 0
|
RBBP6 | retinoblastoma binding protein 6 | 16p12.2 | 0.241 | 0.351 | 1.07e-13
|
GPR65 | G protein-coupled receptor 65 | 14q31-q32.1 | 0.239 | -0.233 | 1.19e-06
|
SRCAP | Snf2-related CREBBP activator protein | 16p11.2 | 0.237 | 0.466 | 0
|
PALB2 | partner and localizer of BRCA2 | 16p12.2 | 0.234 | 0.366 | 7.05e-15
|
SBK1 | SH3 domain binding kinase 1 | 16p11.2 | 0.226 | 0.178 | 0.000215
|
CMIP | c-Maf inducing protein | 16q23 | 0.226 | 0.186 | 0.000115
|
SEPHS2 | selenophosphate synthetase 2 | 16p11.2 | 0.224 | 0.37 | 2.96e-15
|
ANKRD11 | ankyrin repeat domain 11 | 16q24.3 | 0.224 | 0.257 | 8.36e-08
|
PTPRC | protein tyrosine phosphatase, receptor type, C | 1q31-q32 | 0.224 | -0.226 | 2.48e-06
|
GLG1 | golgi glycoprotein 1 | 16q22-q23 | 0.222 | 0.179 | 0.000198
|
PARN | poly(A)-specific ribonuclease | 16p13 | 0.221 | 0.342 | 4.87e-13
|
ERI2 | ERI1 exoribonuclease family member 2 | 16p12.3 | 0.218 | 0.281 | 3.88e-09
|
EIF3CL | eukaryotic translation initiation factor 3, subunit C-like | 16p11.2 | 0.218 | 0.437 | 0
|
RPAP1 | RNA polymerase II associated protein 1 | 15q14 | 0.216 | 0.296 | 5.64e-10
|
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | 16p13.1 | 0.216 | 0.318 | 2.13e-11
|
HINT2 | histidine triad nucleotide binding protein 2 | 9p11.2 | 0.216 | -0.1 | 0.0384
|
LCMT1 | leucine carboxyl methyltransferase 1 | 16p12.1 | 0.215 | 0.336 | 1.27e-12
|
MAFB | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B | 20q12 | 0.213 | -0.144 | 0.00282
|
ARHGAP17 | Rho GTPase activating protein 17 | 16p12.2-p12.1 | 0.212 | 0.4 | 0
|
ARRDC2 | arrestin domain containing 2 | 19p13.12 | 0.212 | -0.271 | 1.54e-08
|
PLK1 | polo-like kinase 1 | 16p | 0.211 | 0.327 | 5.69e-12
|
ERCC4 | excision repair cross-complementation group 4 | 16p13.3 | 0.21 | 0.306 | 1.27e-10
|
CLGN | calmegin | 4q28.3-q31.1 | 0.209 | 0.088 | 0.0694
|
PSIP1 | PC4 and SFRS1 interacting protein 1 | 9p22.2 | 0.208 | -0.124 | 0.0107
|
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 8p22-p21 | 0.207 | -0.07 | 0.15
|
TRAF7 | TNF receptor-associated factor 7, E3 ubiquitin protein ligase | 16p13.3 | 0.207 | 0.294 | 7.51e-10
|
HLA-DMA | major histocompatibility complex, class II, DM alpha | 6p21.3 | 0.206 | -0.297 | 4.97e-10
|
RPGRIP1L | RPGRIP1-like | 16q12.2 | 0.205 | 0.221 | 4.38e-06
|
MYEF2 | myelin expression factor 2 | 15q21.1 | 0.202 | 0.08 | 0.0977
|
MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 1p36 | 0.202 | 0.255 | 1.02e-07
|
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 10q24 | 0.202 | -0.124 | 0.0107
|
HK1 | hexokinase 1 | 10q22 | 0.201 | 0.102 | 0.0344
|
NOMO1 | NODAL modulator 1 | 16p13.11 | 0.201 | 0.41 | 0
|
COASY | CoA synthase | 17q21.2 | 0.199 | 0.141 | 0.00358
|
DHX38 | DEAH (Asp-Glu-Ala-His) box polypeptide 38 | 16q22 | 0.199 | 0.283 | 3.24e-09
|
NOMO2 | NODAL modulator 2 | 16p12.3 | 0.198 | 0.339 | 7.99e-13
|
CLN3 | ceroid-lipofuscinosis, neuronal 3 | 16p12 | 0.197 | 0.244 | 3.6e-07
|
C16orf58 | chromosome 16 open reading frame 58 | 16p11.2 | 0.197 | 0.21 | 1.24e-05
|
TAPBPL | TAP binding protein-like | 12p13.31 | 0.197 | -0.251 | 1.59e-07
|
SOSTDC1 | sclerostin domain containing 1 | 7p21.2 | 0.197 | 0.198 | 4.08e-05
|
PLEC | plectin | 8q24 | 0.197 | 0.053 | 0.276
|
ILF2 | interleukin enhancer binding factor 2 | 1q21.3 | 0.196 | 0.167 | 0.000544
|
ZNF732 | zinc finger protein 732 | 4p16.3 | 0.195 | 0.038 | 0.431
|
PPP1R3E | protein phosphatase 1, regulatory subunit 3E | 14q11.2 | 0.194 | -0.146 | 0.00254
|
NCKIPSD | NCK interacting protein with SH3 domain | 3p21 | 0.193 | -0.028 | 0.564
|
PPP3CC | protein phosphatase 3, catalytic subunit, gamma isozyme | 8p21.3 | 0.193 | -0.19 | 8.15e-05
|
METTL22 | methyltransferase like 22 | 16p13.2 | 0.193 | 0.191 | 7.08e-05
|
GJB5 | gap junction protein, beta 5, 31.1kDa | 1p34.3 | 0.193 | 0.065 | 0.182
|
AMFR | autocrine motility factor receptor, E3 ubiquitin protein ligase | 16q21 | 0.193 | 0.2 | 3.13e-05
|
SH3TC1 | SH3 domain and tetratricopeptide repeats 1 | 4p16.1 | 0.191 | -0.243 | 4.22e-07
|
GPC1 | glypican 1 | 2q35-q37 | 0.191 | 0.117 | 0.016
|
KIFAP3 | kinesin-associated protein 3 | 1q24.2 | 0.19 | 0.135 | 0.00532
|
RPS2P32 | ribosomal protein S2 pseudogene 32 | 7p15.3 | 0.189 | 0.072 | 0.136
|
TDP2 | tyrosyl-DNA phosphodiesterase 2 | 6p22.3-p22.1 | 0.188 | 0.01 | 0.831
|
C16orf72 | chromosome 16 open reading frame 72 | 16p13.2 | 0.188 | 0.274 | 9.76e-09
|
ERAL1 | Era-like 12S mitochondrial rRNA chaperone 1 | 17q11.2 | 0.188 | 0.221 | 4.28e-06
|
PHKB | phosphorylase kinase, beta | 16q12-q13 | 0.188 | 0.112 | 0.0212
|
CTTN | cortactin | 11q13 | 0.187 | 0.055 | 0.258
|
POLR3H | polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) | 22q13 | 0.187 | 0.196 | 4.89e-05
|
TLE3 | transducin-like enhancer of split 3 | 15q22 | 0.187 | 0.144 | 0.00282
|
WBP4 | WW domain binding protein 4 | 13q13.3 | 0.186 | -0.078 | 0.105
|
ZC3HC1 | zinc finger, C3HC-type containing 1 | 7q32.2 | 0.186 | 0.094 | 0.0533
|
C5orf28 | chromosome 5 open reading frame 28 | 5p12 | 0.185 | -0.056 | 0.251
|
CHMP1A | charged multivesicular body protein 1A | 16q24.3 | 0.185 | 0.227 | 2.25e-06
|
E2F2 | E2F transcription factor 2 | 1p36 | 0.185 | 0.18 | 0.000183
|
EDA2R | ectodysplasin A2 receptor | Xq11.1 | 0.185 | -0.064 | 0.186
|
PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 1q31-q32.2 | 0.184 | 0.188 | 9.57e-05
|
C16orf70 | chromosome 16 open reading frame 70 | 16q22.1 | 0.184 | 0.3 | 3.05e-10
|
TBPL1 | TBP-like 1 | 6q23.2 | 0.183 | 0.107 | 0.027
|
GSPT1 | G1 to S phase transition 1 | 16p13.1 | 0.183 | 0.336 | 1.45e-12
|
PIGM | phosphatidylinositol glycan anchor biosynthesis, class M | 1q23.2 | 0.183 | 0.233 | 1.28e-06
|
PWP2 | PWP2 periodic tryptophan protein homolog (yeast) | 21q22.3 | 0.182 | 0.181 | 0.00017
|
PC | pyruvate carboxylase | 11q13.4-q13.5 | 0.182 | 0.13 | 0.0074
|
TRIM58 | tripartite motif containing 58 | 1q44 | 0.182 | 0.102 | 0.0346
|
TANGO6 | transport and golgi organization 6 homolog | 16q22.1 | 0.181 | 0.257 | 8.3e-08
|
ARIH2OS | ariadne homolog 2 opposite strand | 3p21.31 | 0.181 | -0.146 | 0.0026
|
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 1p34.2 | 0.18 | 0.093 | 0.0561
|
PLEKHA8 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 | 7p14.3 | 0.179 | 0.245 | 3.23e-07
|
TSSK6 | testis-specific serine kinase 6 | 19p13.11 | 0.179 | -0.043 | 0.375
|
METTL9 | methyltransferase like 9 | 16p12.2 | 0.177 | 0.329 | 4.1e-12
|
CIAPIN1 | cytokine induced apoptosis inhibitor 1 | 16q21 | 0.176 | 0.287 | 1.81e-09
|
LINC00662 | long intergenic non-protein coding RNA 662 | 19q11 | 0.176 | 0.229 | 1.94e-06
|
SLC1A4 | solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | 2p15-p13 | 0.176 | -0.058 | 0.229
|
DCUN1D3 | DCN1, defective in cullin neddylation 1, domain containing 3 | 16p12.3 | 0.175 | 0.199 | 3.69e-05
|
MED15 | mediator complex subunit 15 | 22q11.2 | 0.174 | 0.04 | 0.405
|
FOXK2 | forkhead box K2 | 17q25 | 0.174 | 0.199 | 3.5e-05
|
POLG | polymerase (DNA directed), gamma | 15q24 | 0.174 | -0.065 | 0.182
|
BMP7 | bone morphogenetic protein 7 | 20q13 | 0.174 | 0.067 | 0.167
|
CCL17 | chemokine (C-C motif) ligand 17 | 16q13 | 0.173 | -0.174 | 0.000311
|
GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 17q25.1 | 0.172 | -0.028 | 0.561
|
HS6ST1 | heparan sulfate 6-O-sulfotransferase 1 | 2q21 | 0.171 | 0.177 | 0.00025
|
DBP | D site of albumin promoter (albumin D-box) binding protein | 19q13.33 | 0.17 | -0.043 | 0.371
|
SPAG6 | sperm associated antigen 6 | 10p12.31 | 0.169 | -0.022 | 0.65
|
TBC1D24 | TBC1 domain family, member 24 | 16p13.3 | 0.169 | 0.331 | 3.05e-12
|
MBTPS1 | membrane-bound transcription factor peptidase, site 1 | 16q24 | 0.168 | 0.209 | 1.44e-05
|
DDB1 | damage-specific DNA binding protein 1, 127kDa | 11q12-q13 | 0.168 | 0.203 | 2.42e-05
|
PHF7 | PHD finger protein 7 | 3p21.31 | 0.167 | -0.08 | 0.101
|
EGF | epidermal growth factor | 4q25 | 0.166 | 0.163 | 0.000717
|
CLTCL1 | clathrin, heavy chain-like 1 | 22q11.2 | 0.164 | 0.166 | 0.000603
|
PLEKHM2 | pleckstrin homology domain containing, family M (with RUN domain) member 2 | 1p36.13 | 0.163 | 0.162 | 0.000788
|
NOMO3 | NODAL modulator 3 | 16p13.11 | 0.161 | 0.284 | 2.66e-09
|
FAM131C | family with sequence similarity 131, member C | 1p36.13 | 0.16 | 0.298 | 3.96e-10
|
MAGED2 | melanoma antigen family D2 | Xp11.2 | 0.16 | -0.103 | 0.0332
|
PRSS30P | protease, serine, 30, pseudogene | 16p13.13 | 0.16 | 0.147 | 0.00242
|
KCNE3 | potassium channel, voltage gated subfamily E regulatory beta subunit 3 | 11q13.4 | 0.158 | -0.153 | 0.00159
|
CD207 | CD207 molecule, langerin | 2p13 | 0.156 | 0.003 | 0.958
|
PANK4 | pantothenate kinase 4 | 1p36.32 | 0.154 | 0.034 | 0.481
|
CPT1C | carnitine palmitoyltransferase 1C | 19q13.33 | 0.151 | 0.193 | 6.39e-05
|
SLC16A14 | solute carrier family 16, member 14 | 2q37.1 | 0.15 | 0.028 | 0.571
|